Xiaohe Yang

3.3k total citations · 1 hit paper
51 papers, 2.7k citations indexed

About

Xiaohe Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaohe Yang has authored 51 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 28 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Xiaohe Yang's work include Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (12 papers) and Metabolism, Diabetes, and Cancer (9 papers). Xiaohe Yang is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (12 papers) and Metabolism, Diabetes, and Cancer (9 papers). Xiaohe Yang collaborates with scholars based in United States, China and Japan. Xiaohe Yang's co-authors include Ann D. Thor, Christopher J. Froelich, Bolin Liu, Susan M. Edgerton, Nipun Saini, Guy S. Salvesen, Douglas R. Green, Henning R. Stennicke, Amanda B. Parris and Sathish Kumar Mungamuri and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Xiaohe Yang

51 papers receiving 2.6k citations

Hit Papers

Pro-caspase-3 Is a Major Physiologic Target of Caspase-8 1998 2026 2007 2016 1998 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohe Yang United States 25 1.8k 818 396 341 243 51 2.7k
In‐Chul Park South Korea 32 1.8k 1.0× 543 0.7× 589 1.5× 228 0.7× 249 1.0× 116 2.8k
Ladislav Anděra Czechia 29 1.9k 1.0× 778 1.0× 435 1.1× 358 1.0× 150 0.6× 79 2.7k
Junji Magae Japan 33 1.9k 1.0× 841 1.0× 690 1.7× 380 1.1× 286 1.2× 136 3.7k
Yoshihiro Sowa Japan 30 2.9k 1.6× 968 1.2× 440 1.1× 205 0.6× 107 0.4× 88 3.7k
Peiwen Fei United States 23 1.8k 1.0× 825 1.0× 576 1.5× 143 0.4× 154 0.6× 51 2.3k
Insoo Bae United States 32 2.5k 1.3× 1.4k 1.7× 688 1.7× 261 0.8× 175 0.7× 61 3.5k
Frederik H. Igney Germany 12 1.5k 0.8× 626 0.8× 343 0.9× 708 2.1× 212 0.9× 21 2.5k
Carmen Ruiz‐Ruiz Spain 27 1.6k 0.8× 656 0.8× 361 0.9× 592 1.7× 251 1.0× 54 2.5k
Olivier Sordet France 36 3.3k 1.8× 1.2k 1.4× 665 1.7× 384 1.1× 178 0.7× 52 4.0k
Enriqué Cepero United States 9 1.5k 0.8× 633 0.8× 354 0.9× 308 0.9× 196 0.8× 11 2.5k

Countries citing papers authored by Xiaohe Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaohe Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohe Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohe Yang more than expected).

Fields of papers citing papers by Xiaohe Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohe Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohe Yang. The network helps show where Xiaohe Yang may publish in the future.

Co-authorship network of co-authors of Xiaohe Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohe Yang. A scholar is included among the top collaborators of Xiaohe Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohe Yang. Xiaohe Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yang, Xiaohe Yang, Yali Wang, et al.. (2021). Targeting SHP2 as a therapeutic strategy for inflammatory diseases. European Journal of Medicinal Chemistry. 214. 113264–113264. 24 indexed citations
2.
Ma, Zhikun, Amanda B. Parris, Meghan B. Davis, et al.. (2020). In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk. International Journal of Molecular Sciences. 21(9). 3095–3095. 11 indexed citations
3.
Shi, Yujie, Zhikun Ma, Qiong Cheng, et al.. (2020). FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(1). 118877–118877. 15 indexed citations
4.
Ma, Zhikun, Young Kim, Xiaoshan Feng, et al.. (2018). DMBA promotes ErbB2‑mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability. Oncology Reports. 40(3). 1632–1640. 11 indexed citations
5.
Saini, Nipun & Xiaohe Yang. (2017). Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. Acta Biochimica et Biophysica Sinica. 50(2). 133–143. 130 indexed citations
6.
Zhao, Ming, et al.. (2017). p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells. PLoS ONE. 12(4). e0175121–e0175121. 20 indexed citations
7.
Zhao, Qingxia, et al.. (2016). Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells. International Journal of Oncology. 49(3). 1203–1210. 44 indexed citations
8.
Zhao, Ming, et al.. (2015). p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells. Biochemical and Biophysical Research Communications. 464(4). 1267–1274. 55 indexed citations
9.
Huang, Jingcao, Shuiliang Wang, Hui Lyu, et al.. (2013). The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells. Molecular Cancer. 12(1). 134–134. 54 indexed citations
10.
Yang, Shihe, Zhikun Ma, Dharmalingam Subramaniam, et al.. (2012). p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription. PLoS ONE. 7(8). e43564–e43564. 24 indexed citations
11.
Huang, Xiaoping, Shuiliang Wang, Choon‐Kee Lee, Xiaohe Yang, & Bolin Liu. (2011). HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance. Cancer Letters. 307(1). 72–79. 36 indexed citations
12.
Kim, Young Mi, et al.. (2011). Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice. Oncology Letters. 2(6). 1077–1081. 2 indexed citations
13.
Kim, Young Mi, Shihe Yang, Weihong Xu, Shibo Li, & Xiaohe Yang. (2008). Continuous in vitro exposure to low-dose genistein induces genomic instability in breast epithelial cells. Cancer Genetics and Cytogenetics. 186(2). 78–84. 6 indexed citations
14.
Liu, Bolin, et al.. (2007). Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells. International Journal of Cancer. 120(9). 1874–1882. 135 indexed citations
15.
Mungamuri, Sathish Kumar, Xiaohe Yang, Ann D. Thor, & Kumaravel Somasundaram. (2006). Survival Signaling by Notch1: Mammalian Target of Rapamycin (mTOR)–Dependent Inhibition of p53. Cancer Research. 66(9). 4715–4724. 211 indexed citations
16.
Nguyen, Marie L., et al.. (2006). Caspase 3 activation during herpes simplex virus 1 infection. Virus Research. 120(1-2). 163–175. 28 indexed citations
17.
Yang, Shihe, Ann D. Thor, Susan M. Edgerton, & Xiaohe Yang. (2006). Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-α induced apoptosis. APOPTOSIS. 11(11). 1987–1997. 40 indexed citations
18.
Turbov, Jane M., et al.. (2001). Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor‐dependent breast cancer cell proliferation and apoptosis in vitro. Journal of Surgical Oncology. 79(1). 17–29. 7 indexed citations
19.
Stennicke, Henning R., Juliane M. Jürgensmeier, Hwain Shin, et al.. (1998). Pro-caspase-3 Is a Major Physiologic Target of Caspase-8. Journal of Biological Chemistry. 273(42). 27084–27090. 649 indexed citations breakdown →
20.
Froelich, Christopher J., Vishva M. Dixit, & Xiaohe Yang. (1998). Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunology Today. 19(1). 30–36. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026